DYNC1I2 anticorps (AA 129-376)
DYNC1I2
Reactivité: Humain
WB, IF
Hôte: Lapin
Polyclonal
unconjugated
N° du produit ABIN1886005
-
-
Antigène
Voir toutes DYNC1I2 Anticorps
-
DYNC1I2
(Dynein, Cytoplasmic 1, Intermediate Chain 2 (DYNC1I2))
-
Épitope
-
AA 129-376
-
Reactivité
-
Humain
-
Hôte
-
Lapin
-
Clonalité
-
Polyclonal
-
Conjugué
-
Cet anticorp DYNC1I2 est non-conjugé
-
Application
-
Western Blotting (WB), Immunofluorescence (IF)
-
Purification
-
Purified by antigen-affinity chromatography.
-
Immunogène
-
Recombinant protein fragment contain a sequence corresponding to a region within amino acids 129 and 376 of human DYNC1I2
-
Top Product
-
Discover our top product DYNC1I2 Anticorps primaire
-
-
-
Indications d'application
-
Suggested dilutions:
Western blotting: 1.500-1.3000
Immunofluorescence: 1.100-1.200
-
Restrictions
-
For Research Use only
-
-
Format
-
Liquid
-
Buffer
-
0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
-
Agent conservateur
-
Thimerosal (Merthiolate)
-
Précaution d'utilisation
-
Biohazard Informations: This product contains thimerosal which is hazardous.
-
Stock
-
4 °C/-20 °C
-
Stockage commentaire
-
Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
Antigène
-
DYNC1I2
(Dynein, Cytoplasmic 1, Intermediate Chain 2 (DYNC1I2))
-
Autre désignation
-
DYNC1I2 (DYNC1I2 Produits)
-
Synonymes
-
anticorps dnci2, anticorps dncic1, anticorps ic2, anticorps dync1i2, anticorps im:7147021, anticorps zgc:153318, anticorps 3110079H08Rik, anticorps AW554389, anticorps Dncic2, anticorps Dnci2, anticorps DNCI2, anticorps IC2, anticorps dynein, cytoplasmic 1, intermediate chain 2, anticorps dynein, cytoplasmic 1, intermediate chain 2 S homeolog, anticorps dynein cytoplasmic 1 intermediate chain 2, anticorps dynein, cytoplasmic 1, intermediate chain 2a, anticorps dync1i2, anticorps dync1i2.S, anticorps DYNC1I2, anticorps dync1i2a, anticorps Dync1i2
-
Poids moléculaire
-
71 kDa
-
ID gène
-
1781
-
NCBI Accession
-
NP_001369, NM_001378
-
Pathways
-
M Phase
-